NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
Clinical Trials
9 trialsNCT05133128 2024-02-22
IMMUNOPBMC
Servier
Phase NA Terminated
NCT02860481 2023-08-24
FRACTal
Institut Curie
Phase NA Terminated
NCT03557749 2023-08-21
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
Masonic Cancer Center, University of Minnesota
Terminated
NCT04833075 2023-05-31
ELICIT
Radboud University Medical Center
Phase NA Terminated
NCT00507325 2022-09-02
Sample Collection From Melanoma Patients
M.D. Anderson Cancer Center
Terminated
NCT02696759 2022-03-16
Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer
University of Arkansas
Phase NA Terminated
NCT00507702 2019-04-18
Identification of Key Blood Molecular Markers for Immunotherapy
Stanford University
Terminated
NCT01598038 2017-07-28
Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma
Centre Francois Baclesse
Phase NA Terminated